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Abstract: The antibacterial activity of the leaf extracts of Eucalyptus camaldulensis was studied against
Klebsiella spp, Salmonella typhi, Yersinia enterocolitica, Pseudomonas aeruginosa (Gram-negative),
Staphylococcus aureus and Bacillus subtilis by the agar diffusion method. The methanol extract,
dichloromethane fraction and methanol residue at 10mg mL  displayed broad spectrum activity against-1
all the test organisms but the petroleum ether fraction showed no activity. The antibacterial activity of the
extracts was compared to the drug gentamycin. The minimum inhibitory concentrations of the methanol
extract and dichloromethane fraction determined by the agar dilution method ranged between 0.04 and
10mg mL  with that of Bacillus subtilis being the least. Phytochemical screening of the plant revealed-1
the presence of tannins, saponins and cardiac glycosides. The results of this study support the traditional
use of Eucalyptus camaldulensis leaves as an antibacterial agent.
Key words: Eucalyptus camaldulensis, antibacterial activity, minimum inhibitory concentration, methanol
extract, dichloromethane fraction.
INTRODUCTION
Plants have been used for the treatment of diseases
all over the world before the advent of modern clinical
drugs and are known to contain substances that can be
used for therapeutic purposes or as precursors for the
synthesis of useful drugs . Thus over 50% of these[14]
modern drugs are of natural products origin and as
such these natural products play an important role in
drug development in the pharmaceutical industry . [7]
Eucalyptus camaldulensis is an important
ethnomedicinal plant belonging to the family,
Myrtaceae. It is used as a remedy for sore throat and
other bacterial infection of the respiratory and urinary
tracts. Essential oils of the leaves are used in the
treatment of lung diseases while the volatile oils are
used as expectorants . Topical ointments containing[2]
eucalyptus oil have also been used in traditional
Aboriginal medicines to heal wounds and fungal
infections. Eucalyptus oil obtained by steam distillation
and rectification of the fresh leaves has Eucalyptol
(1,8-cineole) as its active ingredient and this is
responsible for its various pharmacological actions .[16]
The antimicrobial activities of the methanolic extracts
of E. camaldulensis have also been reported .[3 ,10]
The emergence of bacterial resistance to the
currently available antimicrobial drugs necessitates
further research in the discovery of new safe and
effective antibacterial agents . The investigation of[9]
certain indigenous plants for their antimicrobial activity
is therefore of utmost importance. This study is aimed
at investigating the antimicrobial activity of Eucalyptus
camaldulensis against Gram-positive and Gram-negative
bacteria thereby establishing it as a potential
antimicrobial agent.
MATERIALS AND METHODS
Plant M aterial: Eucalyptus camaldulensis leaves were
collected around the Department of Forestry, University
of Ibadan and authenticated at the Department of
Botany and Microbiology, University of Ibadan. A
voucher specimen was deposited at the Herbarium for
reference purposes. The leaves were air-dried and then
ground before use for this study.
Extraction Procedure: The dried and powdered leaves
(400g) were subjected to soxhlet extraction with
methanol as the extraction solvent. A part of the
methanol extract was then partitioned into petroleum
ether and dichloromethane. The extracts were filtered
and allowed to evaporate to dryness. Each extract was
transferred into clean and dried airtight vials until ready
for use.
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Phytochemical Screening: Samples of Eucalyptus
camaldulensis leaves were screened phytochemically
for the presence of secondary metabolites using the
standard methods of Harbone,  and Trease and Evans[6]
. The secondary metabolites screened for are[15]
saponins, alkaloids, anthraquinones, tannins and cardiac
glycosides.
Bacterial Strains: The organisms used in this study
were four Gram-negative bacteria and two Gram
positive bacteria namely, klebsiella spp, Salmonella
typhi, Yersinia enterocolitica, Pseudomonas aeruginosa
(Gram-negative), Staphylococcus aureus and Bacillus
subtilis (Gram-positive). The organisms were obtained
from the Department of Pharmaceutical Microbiology,
Faculty of Pharmacy, University of Ibadan.
Determination of antibacterial activity: The
antibacterial activity of the extracts was determined
using the agar cup diffusion as described by Adeniyi et
al . A 1 mL of an overnight culture of each bacterial[1]
isolate (equivalent to 10 -10 cfu mL ) was used to seed7 8 -1
sensitivity test agar plates maintained at 45 C. Theo
seeded plates were allowed to set and a sterile cork
borer of 8mm diameter was used to cut equidistant
wells on the surface of the agar. The wells were filled
with 0.1mL solution of each extract reconstituted with
methanol at a concentration of 10mg mL . Gentamycin-1
at 5µg mL  was included as positive control. The-1
plates were incubated at 37 C for 24h after which theo
diameter of zones of inhibition were measured.
Determination of M inimum Inhibitory Concentration
(MIC): The determination of the minimum inhibitory
concentration of the methanol extract and the
dichloromethane fraction was carried out using the agar
dilution method described by Lajubutu et al .[8]
Different concentrations of the extracts were prepared
to give a final concentration in the range of 10 to
0.039 mg mL . 2ml of each dilution was mixed with-1
18ml of Mueller-Hinton agar, poured into Petri dishes
and allowed to set. The agar was streaked with an
overnight broth culture of the test organisms and
incubated overnight. The lowest concentration inhibiting
growth was regarded as the minimum inhibitory
concentration of the extracts.
RESULTS AND DISCUSSION
Qualitative phytochemical screening of the extracts
of E. camaldulensis (Table 1) demonstrated the
presence of tannins, saponins and cardiac glycosides
while anthraquinones and alkaloids were absent.
The results of the antibacterial screening of the
plant leaves (Table 2) revealed that the methanol
extract, dichloromethane fraction and the methanol
residue represent a broad spectrum of activity. All
extracts showed varying degrees of inhibition on the
tested  microorganisms  at a concentration of 10 mg
mL . The methanol extracts showed greater activity-1
against Salmonella typhi, Staphylococcus aureus and
Bacillus subtilis (15 -16mm) than Klebsiella spp,
Yersinia enterocolitica and Pseudomonas aeruginosa
(14mm). The dichloromethane fraction exhibited higher
activity against Klebsiella spp, Salmonella typhi,
Yersinia enterocolitica and Bacillus subtilis (15–16mm)
than Staphylococcus aureus and Pseudomonas
aeruginosa (13-14mm). The methanol residue had a
lower activity against all the test organisms except
Klebsiella spp and Salmonella typhi. The result also
showed that Klebsiella spp and Yersinia enterocolitica
which were not inhibited by gentamycin used as a
positive control in this study were inhibited by the
extracts.  However the petroleum ether fraction showed
no activity on all test organisms.
The minimum inhibitory concentration of the
methanol extract and dichloromethane fraction of the
leaves ranged between 0.04 and 10mg mL  (Table 3).-1
The lowest MICs for both extracts were those for
Bacillus subtilis (0.04 - 0.079 mg mL ).-1
Table 1: Phytochem ical com ponents of the leaf extracts of E.
camaldulensis 
Phytochemical components E. camaldulensis
Alkaloids -
Tannins +
Saponins +
Anthraquinones -
Cardiac Glycosides +
Note: + = Present- = Absent
Discussion: The antibacterial activity of the leaf
extracts of Eucalyptus camaldulensis can be attributed
to the action of the phytochemical compounds it
contains. Babayi et al . reported the presence of[4]
saponins, saponin glycosides, stero id, cardiac
glycosides, tannins, volatile oils, phenols and balsam
(gum) in the plant. The presence of these compounds
in the family Myrtaceae to which E. camaldulensis
belong has been reported by Pamplona-Roger .[11]
Polyphenolic compounds and /or volatile oils are
known to inhibit a wide range of organisms . The[5]
antimicrobial activity of the extracts could be explained
by the presence of tannins. The mechanism of action
of tannins is based on their ability to bind proteins
thereby inhibiting cell protein synthesis . There was[13]
no significant difference in the antimicrobial activity of
the extracts on Gram-negative and Gram positive
bacteria despite the differences in their cell wall
components. Akin-Osanaiye et al . reported the[3]
antibacterial activity of E. camaldulensis extracts
against Staphylococcus aureus while Sherry et al  [12]
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Table 2: Antibacterial activities of the leaf extracts of E. camaldulensis at 10mg mL-1
Organisms M eOH Pet. Ether Dichl. M eOH-residue Gentamycin
Klebsiella spp 14 - 15 15 -
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Salmonella typhi 16 - 15 15 17
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Yersinia enterocolitica 14 - 16 13 -
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Pseudomonas aeruginosa 15 - 14 13 26
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Staphylococcus aureus 15 - 13 14 28
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Bacillus subtilis 16 - 16 14 28
Resistance= no zone of inhibition, Positive control-Gentamycin (5µg mL ), M eOH- M ethanol, Pet. Ether- Petroleum ether fraction, Dichl--1
Dichloromethane fraction.
Table 3: M inim um  Inhibitory Concentration (M IC) of the leaf
extracts of E. camaldulensis
Organisms ME (mg mL ) DF (mg mL )-1 -1
Klebsiella spp 10 10
Salmonella typhi 10 10
Yersinia enterocolitica 0.157 0.625
Pseudomonas aeruginosa 10 10
Staphylococcus aureus 1.25 0.625  
Bacillus subtilis 0.04 0.079
M E= M ethanol Extract, DF= Dichloromethane Fraction
revealed that topical applications of eucalyptus oil
clears methicillin resistant Staphylococcus aureus
infections. The methanol extract of E. camaldulensis
has been found to be effective against staphylococcus
aureus and Bacillus subtilis . The results of the tests[4]
for minimum inhibitory concentration (MIC) revealed
tha t  the  M IC  fo r  Y ers in ia  e n te r o c o l i t ic a ,
Staphylococcus aureus and Bacillus subtilis (between
0.04mg mL  and 0.625mg mL ) were lower than that-1 -1
of Klebsiella spp, Salmonella typhi and Pseudomonas
aeruginosa (10mg mL ). This means that higher doses-1
of the antimicrobial agent will be needed in the
treatment of infections caused by Klebsiella spp,
Salmonella typhi and Pseudomonas aeruginosa
provided they are not toxic to the tissues.
Conclusion: The results of this study have shown that
the leaf extracts of E. camaldulensis have great
potential as antimicrobial agents in the treatment of
infectious organisms. Further detailed investigation of
the active components of the plant for the exact
mechanism of action will contribute greatly to the
development new pharmaceuticals.
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